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Introduction: This study aims to demonstrate the effectiveness of using clinical practice
guideline (CPG) leaﬂets as a communication tool between doctors and patients. We  will col-
lect  basic data on whether using leaﬂets based on traditional Korean medicine (TKM) CPGs
accomplishes the goal of improving clinical decision-making for diagnosis and treatment by
TKM  doctors. We will also evaluate the leaﬂets as a communication tool in the treatment of
lumbar herniated intervertebral discs (HIVDs) in terms of patient and physician satisfaction
and ease of treatment.
Methods and analysis: We  will evaluate efﬁcacy through a comparison of satisfaction and
clinical outcomes in randomly allocated groups of HIVD lumbar patients visiting the Jaseng
Hospital of Korean Medicine who do or do not receive CPG-based treatment. Following the
evaluation, we will make recommendations on whether to implement CPG interventions for
patients selecting TKM treatment after HIVD diagnosis and the method of clinical treatment.rotocol
raditional Korean medicine
Finally, we will evaluate t
and  patients.
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1.  Introduction
Lumbar disk herniation occurs most commonly at approxi-
mately 60 years of age and a large number of patients are
admitted to Korean hospitals for this condition.1 In recent
years, nonsurgical therapy for conservative treatment along
with an increasing use of alternative treatments has been used
for various ailments, including back pain.2,3 In Korea, tradi-
tional Korean medicine (TKM), which includes acupuncture,
herbal medicine, pharmacopuncture, chuna,  and cupping, is
widely used to treat herniated intervertebral discs (HIVDs).4
However, until recently, TKM clinical practice guidelines
(CPGs) for HIVD were inadequate, and additional develop-
ment was needed. A project to develop TKM CPGs for HIVD
began in 2013 and was reported in 2014. While CPGs have
been developed, the more  important process of implementa-
tion still remains. The application of recent, evidence-based
research to clinical practice improves the safety and quality
of real health care.
Although several studies have explored methods that
address the implementation of evidence-based CPGs,5–7 CPG
implementation studies and detailed implementation meth-
ods are currently lacking in literature.
This study focuses on CPGs that were developed to assist in
the diagnosis and treatment of HIVD patients and uses leaﬂets
as a tool for communication between clinicians and patients
to help ensure excellent care and patient satisfaction. Through
this study, we  are attempting to create a novel, evidence-based
implementation process. Finally, we aim to demonstrate the
effectiveness of using CPG leaﬂets as a tool for communication
between doctors and patients.
2.  Methods  and  design
2.1.  Study  design
This paper describes a study protocol for a randomized con-
trolled trial with two  parallel arms and an assessor-blinded
design. The trial will be performed at the Jaseng Korean
Medicine Hospital in Korea in accordance with the Declara-
tion of Helsinki and the Guidelines for Good Clinical Practice.
The protocol of this study has been registered with the Clini-
cal Research Information Service, which is the Korean registry
of the World health Organization Registry Network. Eligible
participants will be randomly divided into either the leaﬂet
group or the standard care group with a 1:1 allocation ratio
(Fig. 1). The evaluation of participants and the analysis of the
results will be performed by professionals blinded to the group
allocation.
2.2.  Study  participants
Inclusion criteria: A total of 50 patients will be recruited
through local advertising and from the outpatient department
at the Jaseng Korean Medicine Hospital. The inclusion criteria
are patients of both sex between the ages of 18 years and 65
years who  have been diagnosed with HIVD using computer
tomography or magnetic resonance imaging. All patients willFig. 1 – A ﬂowchart of the study.
provide informed written consent to participate and agree to
comply with the study regulations.
The exclusion criteria include heart disease, liver disease,
kidney disease, any psychiatric condition, the inability to com-
municate, critical illness, pregnancy, or any condition that
could inﬂuence the study assessment.
2.3.  Randomization
The study participants who meet the eligibility criteria will
be randomly assigned to one of two groups (the leaﬂet group
or the standard care group) at the ﬁrst visit using a central
randomization system with a 1:1 ratio. Randomization will
be conducted with a computer-generated random allocation
sequence using the stratiﬁed block randomization method of
the SAS package (version 9.1.3; SAS Institute, Inc., Cary, NC,
USA) and will be performed by a statistician with no clinical
involvement in this trial. The size of the block will be two. The
allocation concealment will be ensured because the random-
ization code will only be released after the participants are
recruited to the trial and all baseline measurements are taken.
The patients and practitioners will be aware of the allocation
given the routine care setting. However, the outcome asses-
sors and the statistician performing the data analyses will be
masked to the treatment allocation (Table 1).
2.4.  Interventions
Leaﬂets based on CPG: The leaﬂet group will receive an expla-
nation of the overall treatment and diagnosis of HIVD based
on a leaﬂet that includes recommendations and evidence
based on TKM CPGs. This leaﬂet was created to improve the
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Table 1 – Schedule for treatment and outcome
measurements.
Period S T
Visit 1 1
Day 1 1
Informed consent —
Inclusion/exclusion criteria —
Random allocation —
Explanation —
Satisfaction assessment (patients) —
Satisfaction assessment (doctors) —
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clinical approaches.9,10 Based on the above rationale, thisS, screening period; T, treatment period.
ommunication between doctors and patients and to provide
nformation to both groups (Supplementary Fig. 1).
Standard explanation of diagnosis and therapy: The
atients in this group will receive general information
egarding the diagnosis and treatment of HIVD. We  will
onduct standard operation procedure training for every prac-
itioner to unify the process, which will include the following:
1) general diagnosis and method prognosis and (2) adminis-
ration of TKM intervention and other treatments following
rognosis.
.5.  Data  collection
he data will be collected to develop a leaﬂet describing
vidence-based CPGs that will be prepared in collaboration
ith TKM hospitals. Through the analysis of outcome meas-
res, we  will review the pattern of medical treatments derived
rom key recommendations that are based on these evidence-
ased CPGs. In addition, we will prepare a leaﬂet describing
vidence-based CPGs regarding herniation of the lumbar
ertebrae. Thus, we  will be able to evaluate the applicability of
vidence-based clinical practice guidelines in an actual clini-
al setting. All data will be collected and analyzed without the
nclusion of any identifying information.
The outcome measurements will be veriﬁed by an inde-
endent assessor for each patient. These data will be entered
nto the case report form by a certiﬁcated clinical research
oordinator.
When we  receive informed consent from patients, we will
nform the patients as follows: “This study seeks to assist
n treatment decision-making by utilizing a leaﬂet, which
escribes the clinical practice guidelines, as a tool for commu-
ication between patients with lumbar disk herniation (HIVD)
nd the doctor. The basic data collected will be used to help
nsure increases in patient satisfaction and treatment.”
.6.  Types  of  outcome  measurements
rimary outcome measurement: We will use a 5-point Likert
cale to evaluate patient satisfaction with the doctor’s expla-
ation. A clinician will assess the patients. Each variable will
e graded according to the following scale: 1 = bad, 2 = not
ood, 3 = moderate, 4 = good, 5 = very good (Supplementary
able 1).
Secondary outcomes measurement: We will use a 5-point
ikert scale to evaluate doctor satisfaction with the leaﬂet. We163
will use a divided questionnaire for doctors who  use the leaﬂet
and doctors who do not use the leaﬂet for patient communi-
cation. Each variable will be graded according to the following
scale: 1 = bad, 2 = not good, 3 = moderate, 4 = good, 5 = very
good (Supplementary Tables 2 and 3).
2.7.  Sample  size
A power calculation was not used to calculate the sample size
because this research is a pilot study.
2.8.  Statistical  analysis
The statistical analysis will be performed on an intent-to-
treat basis with a 95% conﬁdence interval using multiple
inputs. The intent-to-treat analysis will include all random-
ized patients.
All analyses will be performed with SAS (version 9.1.3; SAS
Institute, Inc., Cary, NC, USA) as follows: (1) descriptive statis-
tics will be used to summarize participant characteristics; (2)
Chi-square tests will be used to compare categorical data, and
paired t-tests will be used to compare continuous data if par-
ticipant characteristics differ among the leaﬂet group and the
typical explanation group; and (3) Chi-square tests and paired
t-tests will be used to compare the outcomes of the leaﬂet
group and the typical explanation group. The primary out-
come will be analyzed with an intention-to-treat analysis. All
statistical tests will be performed using a two-sided 5% level
of signiﬁcance.
3.  Adverse  events
Any expected or unexpected adverse events will be reported by
the participants and practitioners at every visit and followed-
up to completion.
4.  Ethics
This research protocol has been reviewed and approved by the
institutional review board of the trial center (Jaseng Korean
Medicine Hospital, KMJSIRB2015-39). Written informed con-
sent will be obtained from all study participants prior to
enrolment in the study.
5.  Application  of  the  protocol
A CPG can be deﬁned as “A statement developed through a sys-
tematic procedure to promote the decision-making process
between health care practitioners and patients in a speciﬁc
situation.”8 The previous study was conducted over a 3-year
period from January 2013 to December 2015 for the purpose
of developing evidence-based CPGs for TKM as initiated by
the Korean Institute of Oriental Medicine and to standardize
the therapeutic technology of TKM through evidence-basedstudy followed the protocol described in this report to develop
evidence-based CPGs for the treatment of frequently diag-
nosed diseases in the ﬁeld of TKM. The study also attempted
r164  
to improve the quality of medical service and reduce both the
patient risk and cost.
To translate evidence into clinical practice, the clinicians
must be aware of the evidence, agree with it, conﬁdently
deliver the intervention, and adhere to the evidence in appro-
priate situations.11
This study explored methods to increase the utilization
of the existing guidelines in the ﬁeld and in the provision
of quality TKM services. Based on these goals, we prepared
a user-oriented leaﬂet describing preexisting, evidence-based
CPGs and also developed expanded guidelines. We then will
evaluate the satisfaction of both patients and health care prac-
titioners with the applicability of this CPG leaﬂet in a clinical
setting. In addition, we  determined the priority of practices for
which evidence-based CPGs are required. Finally, the current
study will be conducted with the aim of promoting the value
of evidence-based TKM.
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